Current State of Dor Yeshorim, Expanded Carrier, and Newborn Screening: Benefits and Limitations

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Availability and accessibility of preconception and prenatal genetic carrier and newborn biochemical and genetic screening have grown exponentially over the past 2 decades and as such, it is challenging for clinicians to keep pace. Although genetic counseling or genetic consultation should be offered to all expectant and new parents for prenatal screening decisions and positive results, benefits and limitations of these tests and results must be known and familiar to perinatal and pediatric clinicians. A brief historical overview of Dor Yeshorim, preconception and prenatal expanded carrier, and newborn screening is presented, followed by discussion about the conditions screened and considerations surrounding the benefits and limitations of these tests in the practice setting.

Cite

CITATION STYLE

APA

Anderson, S. (2023). Current State of Dor Yeshorim, Expanded Carrier, and Newborn Screening: Benefits and Limitations. MCN The American Journal of Maternal/Child Nursing, 48(5), 266–272. https://doi.org/10.1097/NMC.0000000000000939

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free